Rockwell Medical (RMTI) Depreciation & Amortization (CF) (2010 - 2026)

Rockwell Medical has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $511000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 5.19% year-over-year to $511000.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (changed 0.46% YoY), and the FY2025 full-year result was $2.2 million, up 0.55% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $511000.0, down from $546000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $564000.0 in Q3 2023, with the low at $138000.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $406058.8 across 5 years, with a median of $543000.0 in 2024.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slumped 31.68% — and 2023, when it surged 294.41%.
• Rockwell Medical's Depreciation & Amortization (CF) stood at $154000.0 in 2022, then soared by 257.14% to $550000.0 in 2023, then retreated by 1.27% to $543000.0 in 2024, then grew by 0.55% to $546000.0 in 2025, then decreased by 6.41% to $511000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $511000.0 (Q1 2026), $546000.0 (Q4 2025), and $544000.0 (Q3 2025), per Business Quant data.